What is BEAT's last price and market cap on Chartloom?

The overview shows a last price near n/a and market cap near 0.03B (subject to data latency), alongside the price snapshot and profile on this page.

What P/E and 52-week range are shown for BEAT?

P/E (TTM) is n/a and 52-week range is $0.35 to $4.00 when available from the data feed; see the metrics and chart on this page.

Where do Chartloom’s BEAT figures come from?

Figures are compiled from market data and SEC-backed fundamentals used in the app. Use primary filings and a broker for trading decisions.

What trailing-twelve-month financials does Chartloom show for BEAT?

The company profile lists net income (TTM) near $-28M, EPS (TTM) near $-0.51 when available from the market-data feed. Figures are informational and may lag live markets.

Where is Heartbeam Inc based, and what identifiers does Chartloom list?

The company context section lists headquarters in Santa Clara, California, US, 55.5M shares outstanding, ISIN US42238H1086 when available from company profile and filing metadata.

Heartbeam Inc

$BEAT

Health Care · Health Care Equipment & Supplies

IR Run Scenarios

$0.48

-1.74%

Overview AI Summary Charts Financials Valuation

Profile

Read AI summary

HeartBeam, Inc. is a development stage company, which engages in cardiovascular diagnostic technology. The company is headquartered in Santa Clara, California and currently employs 16 full-time employees. The company went IPO on 2021-10-14. The firm focuses on developing and commercializing higher resolution ambulatory Electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease both inside and outside a healthcare facility setting. The company is engaged in the development of higher resolution ECG solutions is achieved through the development of the Company’s proprietary and patented electrocardiography technology platform. The company is developing three-dimensional (3D) representations of cardiac electrical activity by displaying the spatial locations of ECG waveforms. The company is developing its own product, the HeartBeam System. The HeartBeam System comprises a credit card sized 12-lead output electrocardiogram device, a patient application, a physician portal, and powerful cloud-based algorithms. The core technology consists of a series of patented inventions that allow it to capture the heart’s electrical activity from three distinct directions.

Employees

Website

www.heartbeam.com/

IPO

2021-10-14

Beta

Next earnings date

—

Financials & valuation

Open valuation

Revenue (TTM)

Net income (TTM)